IL1B and non-small cell lung carcinoma: Interleukin-1 beta (IL-1β), a proinflammatory cytokine, associates with NSCLC progress and was found a higher level in serum of NSCLC patients than in healthy donors while increased IL-1β in these patients correlated with poor survival (186).